doi:10.3969/j.issn.1671-2587.2017.03.029

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2017, Vol. 19 ›› Issue (3): 309-312.DOI: 10.3969/j.issn.1671-2587.2017.03.029

• Original Articles • Previous Articles

Received:2017-01-12 Online:2017-06-20 Published:2017-06-23

1 Pang N，Duan X，Jiang M，et al. Reconstitution and clinical significance of T cell subsets in the early stage after related HLA-mismatched peripheral blood hematopoietic SCT without T-cell depletion in vitro[J]. Int J Clin Exp Patho，2015，8（8）：8892.
2 Podgorny P J，Liu Y，Dharmanikhan P，et al. Immune cell subset counts associated with graft-versus-host disease[J]. Biol Blood Marrow Transplant，2014，20（4）：450-462.
3 Fricke S，Hilger N，Fricke C，et al. Prevention of graft-versus-host-disease with preserved graft-versus-leukemia-effect by ex vivo and in vivo modulation of CD4 +，T-cells[J]. Cell Mol Life Sci，2014，71（11）：2135-2148.
4 Hilger N，Glaser J，Müller C，et al. Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ（-/-）（NSG） mice by ex vivo modulation of human CD4（+） T cells[J]. Cytometry A，2016，89（9）：803-815.
5 Ohnuma K，Hatano R，Aune T M，et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes[J]. JImmunol，2015，194（8）：3697-3712.
6 Ito R，Katano I，Kawai K，et al. A novel xenogeneic graft‐versus‐host disease model for investigating the pathological role of human CD4+ or CD8+ T cells using immunodeficient NOG mice[J]. Am J Transplant，2017，17（5）：1216-1228.
7 Sun B. T Helper Cell Differentiation and Their Function[M]. Springer Netherlands，2014，1-230.
8 Betts B C，Sagatys E M，Veerapathran A，et al. CD4+ T cell STAT3 phosphorylation precedes acute GVHD，and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response[J]. J Leukocyte Biol，2015，97（4）：807-819.
9 Amarnath S，Foley J E，Farthing D E，et al. Bone marrow derived mesenchymal stromal cells harness purinergenic signaling to tolerize human th1 cells in vivo[J]. Stem Cells，2015，33（4）：1200-1212.
10 Yi T，Chen Y，Wang L，et al. Reciprocal differentiation and tissue-specific pathogenesis of Th1，Th2，and Th17 cells in graft-versus-host disease[J]. Blood，2009，114（14）：3101-3112.
11 Fu J，Heinrichs J，Yu XZ. Helper T-cell differentiation in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation[J]. Arch Immunol Ther Exp，2014，62（4）：277-301.
12 Messmann J J，Reisser T，Leith?user F，et al. In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity[J]. Blood，2015，126（9）：1138.
13 Brüggen M C，Klein I，Greinix H，et al. Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease[J]. Blood，2014，123（2）：290-299.
14 JiMin Ju，Hakmo Lee，Keunhee Oh，et al. Kinetics of IFN-γ and IL-17 Production by CD4 and CD8 T Cells during Acute Graft-versus-Host Disease[J]. Immune Network，2014，14（2）：89-99.
15 Locke F L，Pidala J，Storer B，et al. CD25 blockade delays Treg reconstitution and does not prevent graft-versus-host disease after allogeneic hematopoietic cell transplantation[J].Biol Blood Marrow Transplant，2017，23（3）：405-411
16 Xhaard A，Moinsteisserenc H，Busson M，et al. Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT[J]. Bone Marrow Transplant，2014，49（8）：1089-1092.
17 Takahashi H，Ikeda K，Ogawa K，et al. CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations[J]. Biol Res，2014，48（1）：1-8.
18 Beres A J，Haribhai D，Chadwick A C，et al. CD8+ FOXP3+ regulatory T cells are induced during graft versus host disease and mitigate disease severity[J].
J Immuno，2012，189（1）：464-474.
19 Zhao K，Ruan S，Tian Y，et al. IL-22 promoted CD3+ T cell infiltration by IL-22R induced STAT3 phosphorylation in murine acute graft versus host disease target organs after allogeneic bone marrow transplantation[J]. Int Immunopharmaco，2016，39：383-388.
20 Fujioka T，Tamaki H，Ikegame K，et al. Frequency of CD4（+）FOXP3（+） regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD[J]. Bone Marrow Transplant，2013，48（6）：859-864.
21 Daniele N，Scerpa M C，Caniglia M，et al. Overview of T-cell depletion in haploidentical stem cell transplantation[J]. Blood Trans，2012，10（3）：264-272.
22 Khandelwal P，Lane A，Chaturvedi V，et al. Peripheral blood CD38 bright CD8+ effector memory T-cells predicts acute graft versus host disease[J]. Biol Blood Marrow Transplant，2015，21（7）：1215-1222.
23 Karimi M A，Bryson J L，Richman L P，et al. NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT[J]. Blood，2015，125（23）：3655-3663.
24 Wu T，Young J S，Johnston H，et al. Thymic damage，impaired negative selection，and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells[J]. JImmunol，2013，191（1）：488-499.
25 Gu J，Lu L，Chen M，et al. TGF-β-induced CD4+Foxp3+ T cells attenuate acute graft-versus-host disease by suppressing expansion and killing of effector CD8+ cells[J]. J Immunol，2014，193
（7）：3388-3397.
26 Wei D，Leigh ND，Bian G，et al. Granzyme B Contributes to the Optimal Graft-Versus-Tumor Effect Mediated by Conventional CD4+ T Cells [J]. J Imm-unol Research & Therapy，2016，1（1）：22-28.
27 Fowler D H，Gress R E. Th2 and Tc2 cells in the regulation of GVHD，GVL，and graft rejection： considerations for the allogeneic transplantation therapy of leukemia and lymphoma[J]. Leuk Lymphoma，2000，38（3-4）：221-234.
28 Mittrücker HW，Visekruna A，Huber M. Heterogeneity in the differentiation and function of CD8 T cells[J]. Arch Immunol Ther Exp，2014，62（6）：449-458.
29 Fowler DH，Gress RE. CD8+ T Cells of Tc2 Phenotype Mediate a GVL Effect and Prevent Marrow Rejection[J]. Vox Sang，1998，74 （Suppl 2）：331-340.
30 Zhao K，Ruan S，Yin L，et al. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease[J]. Mol Med Rep，2016，13（2）：1395-1403.
31 Yu Y，Dapeng W，Chen L，et al. Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and ROR t in mice[J]. Blood，2011，118（18）：5011-5020.
32 Gartlan K H，Markey K A，Varelias A，et al. Tc17 cells are a proinflammatory，plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects[J]. Blood，2015，126（13）：1609-1620.

[1]	ZHAO Jia, SU Man, HE Lu-jun, et al.. Analysis Polymorphisms of KIR Ligands in Hebei Han Population [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(6): 566-569.
[2]	WANG Tian-ju, CHEN Li-ping, WANG Xiao-fang, et al. A Novel HLA-B*67：07 Allele was Identified by Polymerase Chain Reaction-Sequence Based Typing [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(5): 482-486.
[3]	WANG Zhen-lei, ZHAO Jia, HU Guang-lei, et al. Discovery and Idenfication a New Allele of HLA-B*15:201 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2016, 18(5): 434-436.
[4]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2016, 18(2): 197-200.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 4

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact